Active substance
Results for the substance insulin degludec insulin aspart
2 results
About this active substance
The combination of insulin degludec and insulin aspart is used to control blood sugar levels in patients with type 1 and type 2 diabetes. Insulin degludec provides long-term glycemic control, while insulin aspart acts quickly to manage postprandial blood sugar levels.
The medication is administered as a subcutaneous injection, usually once or twice daily, as directed by a doctor. It is important for patients to regularly monitor blood sugar levels and adjust the dose as needed.
Patients should be aware of potential side effects, such as hypoglycemia, injection site reactions, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include hypoglycemia, injection site reactions, and weight gain. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before use.
The medication is administered as a subcutaneous injection, usually once or twice daily, as directed by a doctor. It is important for patients to regularly monitor blood sugar levels and adjust the dose as needed.
Patients should be aware of potential side effects, such as hypoglycemia, injection site reactions, or weight gain. It is important to inform the doctor of any unusual symptoms.
Common side effects include hypoglycemia, injection site reactions, and weight gain. In rare cases, severe allergic reactions may occur. Patients should be informed of these risks before use.